Cargando…
Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine Consortium
PURPOSE: The Cancer Vaccine Consortium of the Cancer Research Institute (CVC-CRI) conducted a multicenter HLA-peptide multimer proficiency panel (MPP) with a group of 27 laboratories to assess the performance of the assay. EXPERIMENTAL DESIGN: Participants used commercially available HLA-peptide mul...
Autores principales: | Britten, Cedrik Michael, Janetzki, Sylvia, Ben-Porat, Leah, Clay, Timothy M., Kalos, Michael, Maecker, Holden, Odunsi, Kunle, Pride, Michael, Old, Lloyd, Hoos, Axel, Romero, Pedro |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2714899/ https://www.ncbi.nlm.nih.gov/pubmed/19259668 http://dx.doi.org/10.1007/s00262-009-0681-z |
Ejemplares similares
-
A critical assessment for the value of markers to gate-out undesired events in HLA-peptide multimer staining protocols
por: Attig, Sebastian, et al.
Publicado: (2011) -
Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI)
por: Janetzki, Sylvia, et al.
Publicado: (2007) -
Advancing the field of cancer immunotherapy: MIATA consensus guidelines become available to improve data reporting and interpretation for T-cell immune monitoring
por: Hoos, Axel, et al.
Publicado: (2012) -
Toward the harmonization of immune monitoring in clinical trials: Quo vadis?
por: Britten, C. M., et al.
Publicado: (2007) -
Immunological Monitoring to Rationally Guide AAV Gene Therapy
por: Britten, Cedrik Michael, et al.
Publicado: (2013)